Synthesis and application of four new conjugates of camptothecin-steroid
A technology of camptothecin and conjugates, which is applied in the field of medicinal chemistry and can solve problems such as destroying the integrity of the E ring
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0031] Preparation of 20(S)-O-3β-hydroxy-5-androstene-17β-acylcamptothecin (CPT-1)
[0032] Add 3β-hydroxy-5-androstene-17β-carboxylic acid (280mg, 0.88mmol) into anhydrous dichloromethane (30mL) in a 100mL reaction flask and stir to dissolve at room temperature, then add EDC·HCl (200mg, 1.04 mmol), DMAP (213mg, 1.75mmol) and camptothecin (100mg, 0.29mmol). Stir the reaction at room temperature under the protection of argon, and monitor it by TLC. After the reaction, pour into a separatory funnel and add 50 mL of dichloromethane, and then wash with 0.1mol / L HCl and saturated brine respectively. The organic layer is dried with anhydrous magnesium sulfate, and the organic layer is concentrated. layer, concentrated the residue and pressurized column chromatography v(chloroform):v(methanol)=150:1~50:1 as the eluent to obtain the product (CPT-1).
[0033] The product (CPT-1) is a yellow powdery solid (75mg, yield 40.2%), mp: 268-271℃; 1 H NMR (CDCl 3 ,600MHz)δ:8.40(s,1H),8.19(d,...
Embodiment 2
[0035] Preparation of 20(S)-O-3β-acetoxy-5-androstene-17β-acylcamptothecin (CPT-2)
[0036]Add 3β-acetoxy-5-androstene-17β-carboxylic acid (317mg, 0.88mmol) and anhydrous dichloromethane (30mL) into a 100mL reaction flask and stir to dissolve at room temperature, then add EDC·HCl (200mg , 1.04mmol), DMAP (213mg, 1.75mmol) and camptothecin (100mg, 0.29mmol). Stir the reaction at room temperature under the protection of argon, and monitor it by TLC. After the reaction, pour into a separatory funnel and add 50 mL of dichloromethane, and then wash with 0.1mol / L HCl and saturated brine respectively. The organic layer is dried with anhydrous magnesium sulfate, and the organic layer is concentrated. layer, concentrated the residue and pressurized column chromatography v (chloroform): v (methanol) = 150:1 ~ 50:1 as the eluent to obtain the product (CPT-2).
[0037] The product (CPT-2) is a yellow-white powdery solid (85mg, yield 42.8%), mp: 235-238℃, 1 H NMR (CDCl 3 ,600MHz)8.41(s,...
Embodiment 3
[0039] Preparation of 0(S)-O-androst-4-ene-17β-acylcamptothecin (CPT-3)
[0040] Add androst-4-ene-17β-carboxylic acid (278mg, 0.88mmol) and anhydrous dichloromethane (30mL) into a 100mL reaction flask and stir to dissolve at room temperature, then add EDC·HCl (200mg, 1.04mmol), DMAP (213mg, 1.75mmol) and camptothecin (100mg, 0.29mmol). Stir the reaction at room temperature under the protection of argon, and monitor it by TLC. After the reaction, pour into a separatory funnel and add 50 mL of dichloromethane, and then wash with 0.1mol / L HCl and saturated brine respectively. The organic layer is dried with anhydrous magnesium sulfate, and the organic layer is concentrated. layer, concentrated the residue and pressurized column chromatography v (chloroform): v (methanol) = 150:1 ~ 50:1 as the eluent to obtain the product (CPT-3).
[0041] The product (CPT-3) was a yellow-white powdery solid (85 mg, yield 45.8%). mp:253-256℃, 1 H NMR (CDCl 3 ,600MHz)8.40(s,1H),8.18(d,1H,J=9.0...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 